NYU Langone creates new groundbreaking collaboration in autism research

NewsGuard 100/100 Score

NYU Langone Medical Center announced today the creation of a new groundbreaking collaboration in autism research. The Autism Brain Imaging Data Exchange (ABIDE) is a database of brain scans from more than 15 leading international research institutions and academic medical centers. ABIDE was designed to advance scientific understanding of Autism Spectrum Disorder (ASD) by allowing researchers to share autism data within the broader scientific community. The collaboration is led by NYU Langone, coordinator of ABIDE and the single largest contributor of research to the consortium, and Kennedy Krieger Institute.

"This collaboration fills an unmet need among the autism research community. By providing access to an unprecedented large-scale dataset, ABIDE has the potential to move autism research forward and thus advance our understanding of a complex disorder," said Adriana Di Martino, MD, co-founder and coordinator of ABIDE and Leon Levy assistant professor of child and adolescent psychiatry at the Child Study Center at NYU Langone Medical Center. "We are honored that some of the world's leading institutions have contributed data and truly feel this initiative will help to change the face of autism research. This is only the beginning."

According to the Centers for Disease Control and Prevention, one in every 88 children in the U.S. is diagnosed with an Autism Spectrum Disorder by age 8. A key focus area for autism research is brain imaging to map out the pathology of disease, which can lead to important new understandings about the function and structures of the brain.

ABIDE was created to facilitate and advance autism research and is expected to contribute to increasing collaboration within the autism research community. ABIDE currently includes brain images from more than 1,000 individuals, ages 6 to 64 years old, aggregated from more than 15 leading medical and research institutions around the world.

"Acquiring imaging data in children with autism can be challenging. By establishing a collaborative environment for data sharing, ABIDE helps us overcome obstacles and will undoubtedly lead to progress in understanding brain structure and function in autism," said Dr. Stewart Mostofsky, co-founder of ABIDE and Director of the Laboratory for Neurocognitive and Imaging Research at Kennedy Krieger Institute. "This is a vital demonstration of how the scientific community can become more cooperative and, by working together, increase our knowledge to help improve autism diagnosis and treatment."

ABIDE represents an unparalleled resource for researchers and clinicians in the autism field, according to Glenn Saxe, MD, the Arnold Simon Professor and Chair of the Department of Child and Adolescent Psychiatry, and director of the Child Study Center at NYU Langone.

"The magnitude of this initiative cannot be overstated as it may potentially change the landscape of autism research, advance the discovery of diagnostic tools and treatments and most importantly, ultimately help us provide the highest level of patient care to children with this debilitating disorder," he added. "We hope the ABIDE initiative will become a model for other research areas, as innovation drives the advancement of ideas."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study reveals how genetic changes in SCN2A gene impact autism and epilepsy